| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.
|
J Clin Oncol
|
2002
|
3.75
|
|
2
|
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.
|
J Clin Oncol
|
1997
|
1.94
|
|
3
|
Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study.
|
Cancer
|
1995
|
1.35
|
|
4
|
Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.
|
Int J Biol Markers
|
2004
|
1.35
|
|
5
|
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer.
|
Br J Cancer
|
2004
|
1.20
|
|
6
|
Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
|
J Clin Oncol
|
1994
|
1.15
|
|
7
|
Supportive care in patients with advanced non-small-cell lung cancer.
|
Br J Cancer
|
2003
|
1.04
|
|
8
|
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
|
Br J Cancer
|
2001
|
0.96
|
|
9
|
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
|
Br J Cancer
|
1999
|
0.95
|
|
10
|
Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
|
Br J Cancer
|
1998
|
0.94
|
|
11
|
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators.
|
Br J Cancer
|
2000
|
0.89
|
|
12
|
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
|
Lung Cancer
|
2001
|
0.86
|
|
13
|
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
|
Br J Cancer
|
1999
|
0.85
|
|
14
|
[Traumatic rupture of the diaphragm caused by closed injury].
|
Chir Ital
|
1978
|
0.85
|
|
15
|
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer.
|
Ann Oncol
|
1999
|
0.83
|
|
16
|
Oral etoposide as second-line chemotherapy for colorectal cancer: a GISCAD study. Gruppo Italiano Studio Carcinomi Apparato Digerente.
|
J Chemother
|
1995
|
0.80
|
|
17
|
Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer.
|
Int J Biol Markers
|
2005
|
0.80
|
|
18
|
A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretion.
|
Anticancer Res
|
2005
|
0.80
|
|
19
|
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
|
Ann Oncol
|
2000
|
0.79
|
|
20
|
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
|
Ann Oncol
|
2003
|
0.79
|
|
21
|
Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
|
Br J Cancer
|
1990
|
0.79
|
|
22
|
Increasing doses of 5-fluorouracil and high-dose folinic acid in the treatment of metastatic colorectal cancer.
|
Tumori
|
1999
|
0.79
|
|
23
|
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study.
|
Br J Cancer
|
2001
|
0.78
|
|
24
|
Vinorelbine as single agent in pretreated patients with advanced breast cancer.
|
Tumori
|
1994
|
0.78
|
|
25
|
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
|
Ann Oncol
|
2000
|
0.78
|
|
26
|
Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.
|
Anticancer Res
|
2000
|
0.77
|
|
27
|
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.
|
Br J Cancer
|
2004
|
0.76
|
|
28
|
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen.
|
Br J Cancer
|
2002
|
0.75
|
|
29
|
The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival results.
|
Int J Biol Markers
|
2005
|
0.75
|
|
30
|
[Early diagnostic laparotomy in patients with multiple injuries (apropos of 125 cases)].
|
Chir Ital
|
1977
|
0.75
|
|
31
|
[Personal experience with the treatment of recurrent varices of the lower limbs].
|
Chir Ital
|
1977
|
0.75
|
|
32
|
[Our experience in the treatment of inguinal hernia using a silastic-dacron prosthesis].
|
Chir Ital
|
1977
|
0.75
|
|
33
|
Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer.
|
Tumori
|
1999
|
0.75
|
|
34
|
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.
|
Ann Oncol
|
1997
|
0.75
|
|
35
|
[Adjuvant therapy of colon cancer. State of the art and future perspectives].
|
Tumori
|
1999
|
0.75
|
|
36
|
Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer.
|
Int J Biol Markers
|
2017
|
0.75
|
|
37
|
[Postoperative hyperamylasemia in surgery of the biliary tract (clinical contribution)].
|
Chir Ital
|
1980
|
0.75
|
|
38
|
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-up.
|
Oncology
|
2004
|
0.75
|
|
39
|
[Cancer of the gastric stump after gastroduodenal resection for peptic ulcer disease. Our experience].
|
Minerva Chir
|
1986
|
0.75
|
|
40
|
Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
|
Oncology
|
1993
|
0.75
|
|
41
|
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer.
|
Ann Oncol
|
1999
|
0.75
|
|
42
|
[A case of primary duodenal cancer. Diagnostic and therapeutic considerations].
|
Radiol Med
|
1983
|
0.75
|
|
43
|
[New drugs for colorectal cancer: UFT].
|
Tumori
|
2001
|
0.75
|
|
44
|
[Technical considerations and preliminary experiences in the use of a mechanical suture apparatus in anastomoses of the digestive tract].
|
Chir Ital
|
1981
|
0.75
|
|
45
|
[Multiple primary neoplasms].
|
Chir Ital
|
1982
|
0.75
|